These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20699625)

  • 1. Retinal and ocular toxicity in ocular application of drugs and chemicals--part II: retinal toxicity of current and new drugs.
    Penha FM; Rodrigues EB; Maia M; Furlani BA; Regatieri C; Melo GB; Magalhães O; Manzano R; Farah ME
    Ophthalmic Res; 2010; 44(4):205-24. PubMed ID: 20699625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal and ocular toxicity in ocular application of drugs and chemicals--part I: animal models and toxicity assays.
    Penha FM; Rodrigues EB; Maia M; Dib E; Fiod Costa E; Furlani BA; Nunes Moraes Filho M; Dreyfuss JL; Bottós J; Farah ME
    Ophthalmic Res; 2010; 44(2):82-104. PubMed ID: 20484950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs and the retina.
    Constable S; Pirmohamed M
    Expert Opin Drug Saf; 2004 May; 3(3):249-59. PubMed ID: 15155152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordings.
    Rosolen SG; Kolomiets B; Varela O; Picaud S
    Exp Toxicol Pathol; 2008 Jun; 60(1):17-32. PubMed ID: 18294830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel drug delivery systems for retinal diseases. A review.
    Lee SS; Robinson MR
    Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the retinal toxicity of intraocular glucocorticoids.
    Torriglia A; Valamanesh F; Behar-Cohen F
    Biochem Pharmacol; 2010 Dec; 80(12):1878-86. PubMed ID: 20654583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal toxicity of chloroquine hydrochloride administered by intraperitoneal injection.
    Gaynes BI; Torczynski E; Varro Z; Grostern R; Perlman J
    J Appl Toxicol; 2008 Oct; 28(7):895-900. PubMed ID: 18484088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A current practice for predicting ocular toxicity of systemically delivered drugs.
    Somps CJ; Greene N; Render JA; Aleo MD; Fortner JH; Dykens JA; Phillips G
    Cutan Ocul Toxicol; 2009; 28(1):1-18. PubMed ID: 19514919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
    Baath JS; Lam WC; Kirby M; Chun A
    Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of drugs to eye melanin is not predictive of ocular toxicity.
    Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity.
    Zemel E; Loewenstein A; Lei B; Lazar M; Perlman I
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1875-84. PubMed ID: 7635661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
    Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current in vivo assays for cutaneous toxicity: local and systemic toxicity testing.
    Auletta CS
    Basic Clin Pharmacol Toxicol; 2004 Nov; 95(5):201-8. PubMed ID: 15546473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Examination strategies in the diagnosis of drug-induced retinal damage].
    Niemeyer G; Früh B
    Klin Monbl Augenheilkd; 1989 May; 194(5):355-8. PubMed ID: 2664326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal pharmacotherapy: applications in retinal disease.
    Prasad AG; Schadlu R; Apte RS
    Compr Ophthalmol Update; 2007; 8(5):259-69. PubMed ID: 18201513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal toxicity of intravitreal genistein in a rabbit model.
    Fiore T; Iaccheri B; Pietrolucci F; Giansanti F; Cavaliere A; Coltella R; Mameli MG; Androudi S; Brazitikos P; Cagini C
    Retina; 2010 Oct; 30(9):1536-41. PubMed ID: 20634778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal toxicity of systemic medications.
    Labriola LT; Jeng D; Fawzi AA
    Int Ophthalmol Clin; 2012; 52(1):149-66. PubMed ID: 22124243
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal toxicities of cancer therapy drugs: biologics, small molecule inhibitors, and chemotherapies.
    Liu CY; Francis JH; Brodie SE; Marr B; Pulido JS; Marmor MF; Abramson DH
    Retina; 2014 Jul; 34(7):1261-80. PubMed ID: 24949716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.